Baynes Roy D. bought EIKN
March 2, 2026 · Form 4 insider transaction
Baynes Roy D. bought 134,088 shares of Eikon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
134,088
Price
$0.00
Total value
N/A
InsiderBaynes Roy D.
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after134,088
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.